Safety and efficacy of non-reduced use of caspofungin in patients with Child –Pugh B or C cirrhosis: a real-world study
ConclusionsStandard-dose of caspofungin can be safely and effectively used in patients with Child –Pugh B or C cirrhosis, and we appealed to re-assess the most suitable dosing regimen in this population to avoid a potential subtherapeutic exposure.
Source: Infection - Category: Infectious Diseases Source Type: research
More News: Cancidas | Caspofungin | Children | China Health | Cirrhosis | Drugs & Pharmacology | Electronic Medical Records (EMR) | Infectious Diseases | Study